Get unlimited access to our best features
Subscribe now
FDA image


Stay current with all the latest and breaking news from FDA, compare headlines and perspectives between news sources on stories happening today. In total, 1,152 stories have been published about FDA which Ground News has aggregated in the past 3 months.

Latest News Stories


FDA warns against use of baby neck floats after child dies

100% Center coverage: 5 sources
An infant has died and another was hospitalized while using the item. It is also possible that some incidents have not been reported to the agency. Neck floats are inflatable plastic rings worn around a baby's neck that allow babies to float freely in the water. Anyone who has experienced issues associated with using neck floats is encouraged to file a voluntary report.See the Story
Europe · Geneva

Omicron sub-variants BA.4, BA.5 make up most of COVID-19 cases: WHO

60% Center coverage: 5 sources
Two Omicron subvariants are now causing more than half of new coronavirus infections in the United States. Both are very good at dodging antibodies in people who have been vaccinated and boosted. First spotted by scientists in South Africa in January and February this year, they became dominant in the U.S. in less than two months.See the Story
US & Canada

FDA warns against baby neck floats after child dies, another hospitalized

Coverage: 4 sources
The inflatable plastic rings can be worn around a baby's neck, letting the infant float freely in water. Some are marketed for those as young as two weeks old, as well as premature babies or those with developmental delays or disabilities. The FDA said the effectiveness of the products has not been established.See the Story

Vaccine Makers to Update Boosters to Target Omicron Subvariants

Coverage: 2 sources
FDA asks vaccine makers to update COVID-19 booster shots to target Omicron subvariants. Pfizer and Moderna are expected to start producing reformulated doses this summer. BA.4 and BA.5 now account for more than half of all new COVID cases in the United States.See the Story

FDA won’t require lengthy clinical trials for COVID-19 boosters – TechCrunch

Coverage: 2 sources
The FDA will instead rely on data from trials on shots developed earlier in the pandemic to combat specific virus variants. New boosters are expected to be available in the fall fall. It remains unclear, however, how many eligible folks will seek them out. Across the U.S., over 78% of the population has received at least one vaccine dose.See the Story
Asia · Thailand

Thailand adjusting endemic transition and assessing BA.4, BA.5 sub-variants of Omicron

The CCSA talk on the endemic transition plan will take place on July 8 instead of July 1. The postponement is due to the recent easing of disease control measures. The health ministry is now making the said adjustments and will be presenting the plan to the CCSA meeting for acknowledgment and endorsement.See the Story
FDA · Des Moines

New FDA-approved treatment cures hair loss in alopecia areata patients

100% Center coverage: 1 sources
Christian Daniels was 24 when he was diagnosed with the autoimmune skin disease Alopecia Ariana. The body's immune system attacks hair follicles, causing hair to fall out often in clumps. Christian took part in a study at Yale University School of Medicine testing a drug from Eli Lilly, baricitinib or olumiant.See the Story

Oklahoma vaping shop sees surge in Juul sales as court reviews FDA ban

100% Center coverage: 1 sources
The FDA banned the vaping devices, and then it was lifted after Juul filed an emergency appeal with the FDA.See the Story

Breaking News Topics Related to FDA